HFCVX | VIVIX | HFCVX / VIVIX | |
Total Expense Ratio | 1.22 | 0.04 | 3,050% |
Annual Report Gross Expense Ratio | 1.22 | 0.04 | 3,050% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | 8.898 | 2.452 | 363% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 292M | 189B | 0% |
Annual Yield % from dividends | 3.08 | 2.29 | 135% |
Returns for 1 year | 13.82 | 8.01 | 172% |
Returns for 3 years | 19.30 | 32.19 | 60% |
Returns for 5 years | 76.58 | 72.56 | 106% |
Returns for 10 years | 46.58 | 103.54 | 45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LHCQX | 17.93 | -0.10 | -0.55% |
Lord Abbett Health Care R3 | |||
JLCVX | 70.98 | -0.89 | -1.24% |
JHancock Fundamental Large Cap Core R5 | |||
TRGVX | 18.21 | -0.23 | -1.25% |
T. Rowe Price Glbl Val Eq | |||
GSMGX | 13.37 | -0.23 | -1.69% |
Goldman Sachs Small/Mid Cap Growth C | |||
RPMFX | 15.11 | -0.34 | -2.20% |
Reinhart Genesis PMV Advisor |